Late last year, CMS issued a proposed rule recommending significant revisions to regulations governing Medicare Advantage health plans. These proposed changes, if finalized, would have far-reaching effects on MA plans, impacting areas including Star Ratings, access to care, health equity, and beneficiary protections.
Join industry experts from Cureatr and Rex Wallace Consulting for a deep dive into some of the most noteworthy medication management-related provisions outlined in the 2024 proposed rule. Our panelists will dig into the rationale behind these proposed changes, how they would impact MA health plans, and best practices health plans should put in place now to be adequately prepared for 2024 and beyond.
![]() |
Morgan Beschle |
![]()
|
Rex Wallace |
![]() |
Jessica Muratore |
© Cureatr 2023
HEDIS® is a registered trademark of the National Committee for Quality Assurance (NCQA).